Showing 2161-2170 of 6036 results for "".
- Lensar and Oertli Provide Update on Plans to Integrate Phaco Technology into the ALLY Adaptive Cataract Treatment Systemhttps://modernod.com/news/lensar-and-oertli-provide-update-on-plans-to-integrate-phaco-technology-into-the-ally-adaptive-cataract-treatment-system/2481923/Lensar said it is closer to its plans to integrate phacoemulsification technology from Oertli Instrumente into the ALLY Adaptive Cataract Treatment System. Oertli filed with the FDA a 510(k) for their Faros device, which if cleared, will bring Lensar a step closer to deliver comb
- Study Finds Role of Biosynthetic Fatty Acid Pathway Insufficiencies in Age-Related Macular Degenerationhttps://modernod.com/news/study-finds-role-of-biosynthetic-fatty-acid-pathway-insufficiencies-in-age-related-macular-degeneration/2481831/LSU Health Sciences Center announced the publication of findings that suggest that age-related macular degeneration (AMD) decreases an essential fatty acid, preventing the formation of a class of protective molecules and reducing repair potential. The research was led by Nicolas Bazan,
- Oculis’ OCS-01 Eye Drops Studied in LEOPARD Trial to Treat Cystoid Macular Edemahttps://modernod.com/news/oculis-ocs-01-eye-drops-studied-in-leopard-trial-to-treat-cystoid-macular-edema/2481763/Oculis announced that the first patient has been enrolled in the investigator-initiated LEOPARD trial evaluating the potential of OCS-01 eye drops, Oculis’ high-concentration preservative-free topical Optireach formulation of dexamethasone, for the treatment of cystoid macular edema (CME).<
- Bausch + Lomb Announces Changes to its Leadership Teamhttps://modernod.com/news/bausch-lomb-solidifies-leadership-team/2481761/Bausch + Lomb announced changes to its executive leadership team, including the creation of two new roles. This development follows reshuffling announced in early June after chairman and CEO Brent Saunders rejoined B
- Shamir Insight Launches 'Driver Intelligence' Lens Technologyhttps://modernod.com/news/shamir-insight-launches-driver-intelligence-lens-technology/2481754/Shamir Insight announced the launch of Driver Intelligence, a lens technology designed to optimize visual performance and deliver superior clarity for drivers any time of the day, enabling safer driving. Shamir Insight worked closely with the Renault
- Smartlens Closes $6.1 Million Series A Financing to Advance miLens Devicehttps://modernod.com/news/smartlens-closes-61-million-series-a-financing-to-advance-milens/2481727/Smartlens has closed an oversubscribed $6.1 million Series A equity financing round to advance regulatory clearance for miLens, a novel, electronics-free, soft contact lens for monitoring diurnal IOP. The miLens device is an electronics free soft contact lens that uses mi
- Euclid Announces ABB Optical Group as Licensed Manufacturer and Distributor of Euclid Ortho-K Lenseshttps://modernod.com/news/euclid-announces-abb-optical-group-as-licensed-manufacturer-and-distributor-of-euclid-ortho-k-lenses/2481691/Euclid Vision has announced that ABB Optical Group is now a licensed manufacturer and distributor of the company’s Ortho-K lenses. Financial terms of the deal were not disclosed. ABB, which Euclid says is the largest distributor of soft lenses in the United States,
- The International Agency for the Prevention of Blindness (IAPB) Welcomes Over 300 International Delegates to Singaporehttps://modernod.com/news/the-international-agency-for-the-prevention-of-blindness-iapb-welcomes-over-300-international-delegates-to-singapore/2481690/The International Agency for the Prevention of Blindness (IAPB) has welcomed more than 300 delegates to Singapore for its "2030 IN SIGHT LIVE" event. Hosted in partnership with the Singapore Eye Research Institute (SERI), the event gathers experts and thought leaders from eye
- Cellusion Raises $21 Million to Advance iPS Cell-Derived Corneal Endothelial Cell Substitutehttps://modernod.com/news/cellusion-raises-21-million-to-advance-ips-cell-derived-corneal-endothelial-cell-substitute/2481659/Tokyo-based Cellusion announced that it has raised 2.83 billion yen ($21 million USD) in Series C Round financing. The funding will be used to promote its lead program—the development of iPS cell-derived corneal endothelial cell substitute (CLS001) to resolve the challenge of
- Bausch + Lomb Launches Biotrue Hydration Boost Contact Lens Rehydrating Drops in the United Stateshttps://modernod.com/news/bausch-lomb-launches-biotrue-hydration-boost-contact-lens-rehydrating-drops-in-the-united-states/2481653/Bausch + Lomb announced the US launch of Biotrue Hydration Boost Contact Lens Rehydrating drops, which the company describes as the first and only preservative-free rehydrating drop in a multi-dose bottle that is indicated to lubricate and rewet soft contact lenses, including daily